Market Alert: Pluristem (PSTI) New Indication in Heart Disease… May 18, 2012 by Ray Dirks Pluristem Therapeutics' (PSTI) Platform Technology Shows Promise in Large New Clinical Indication: Heart Disease
By Ray Dirks
New Indication May Boost Company Valuation
Tuesday, PSTI revealed preclinical data showing that its platform technology, PLX cells, is effective in a type of heart disease that has no current cures.
The condition is known as diabetic diastolic dysfunction, a subset of diastolic heart disease that occurs when one or both ventricles of the heart suffer in performance, leading to heart failure....